NLM Logo

fisogatinib MeSH Supplementary Concept Data 2025


MeSH Supplementary
fisogatinib
Unique ID
C000709257
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C000709257
Entry Term(s)
2-propenamide, N-((3S,4S)-3-((6-(2,6-dichloro-3,5-dimethoxyphenyl)-2-quinazolinyl)amino)tetrahydro-2H-pyran-4-yl)-
BLU-554
N-((3S,4S)-3-((6-(2,6-dichloro-3,5-dimethoxyphenyl)quinazolin-2-yl)amino)oxan-4-yl)prop-2-enamide
N-((3S,4S)-3-((6-(2,6-dichloro-3,5-dimethoxyphenyl)quinazolin-2-yl)amino)tetrahydro-2H-pyran-4-yl)acrylamide
Pharm Action
Antineoplastic Agents
Registry Numbers
5Q7R99CKV2
Heading Mapped to
*Pyrans
*Quinazolines
Frequency
4
Note
fibroblast growth factor receptor 4 (FGFR4) inhibitor
Source
Int J Pharm. 2020 Jan 5;573:118842.
Date of Entry
2020/08/03
Revision Date
2022/02/09
fisogatinib Preferred
2-propenamide, N-((3S,4S)-3-((6-(2,6-dichloro-3,5-dimethoxyphenyl)-2-quinazolinyl)amino)tetrahydro-2H-pyran-4-yl)- Broader
BLU-554 Narrower
page delivered in 0.005s